{
  "ticker": "JNJ",
  "target_date": "2025-08-14",
  "actual_date": "2025-08-14",
  "collected_at": "2025-12-08T12:08:34.314110",
  "price": {
    "open": 171.95,
    "high": 173.34,
    "low": 170.38,
    "close": 172.3525848388672,
    "volume": 8241700,
    "change_1d_pct": 0.17,
    "change_7d_pct": 2.33,
    "change_30d_pct": 12.32
  },
  "technicals": {
    "rsi_14": 65.81,
    "sma_20": 167.18,
    "sma_50": 158.67,
    "macd": 3.857,
    "macd_signal": 3.689,
    "macd_histogram": 0.168,
    "bb_upper": 173.8,
    "bb_lower": 160.56,
    "price_vs_sma20_pct": 3.09,
    "price_vs_sma50_pct": 8.62,
    "volume_ratio": 0.98
  },
  "fundamentals": {
    "market_cap": 488508653568,
    "pe_ratio": 19.571428,
    "forward_pe": 19.128302,
    "price_to_book": 6.1541266,
    "price_to_sales": 5.301291,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.43,
    "pct_from_52w_low": 44.13
  },
  "macro": {
    "spy": {
      "price": 643.17,
      "change_1d_pct": 0.01,
      "change_7d_pct": 1.92
    },
    "vix": {
      "level": 14.83,
      "signal": "LOW_FEAR"
    },
    "treasury_10y": {
      "yield_pct": 4.29
    },
    "dollar_index": {
      "level": 98.25
    },
    "gold": {
      "price": 3335.2
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "FDA approved AI device that predicts cancer prognosis",
      "source": "Yahoo",
      "datetime": 1755187292,
      "summary": "The ArteraAI prostate test uses artificial intelligence and biomarkers to predict if standard hormone therapy will be effective and for how long.",
      "url": "https://finnhub.io/api/news?id=8a1d3087a2a07b626010064cadc612315fefb2fe10ffc284864907bfd06c22b1"
    },
    {
      "headline": "Back To Basics: Why I Favor Amgen Over Johnson & Johnson",
      "source": "SeekingAlpha",
      "datetime": 1755184015,
      "summary": "Amgen (AMGN) and Johnson & Johnson (JNJ) recently received a 60-day ultimatum to lower prices in the U.S. market. A fundamental analysis shows AMGN to be better positioned. Read more here.",
      "url": "https://finnhub.io/api/news?id=b05d8175133f66cab3c53b74e587259f1ca29ba6b210173f4902d37e435e0b01"
    },
    {
      "headline": "BNY Mellon Dynamic Value Fund Q2 2025 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1755172800,
      "summary": "BNY Mellon Dynamic Value Fund (Class A at NAV) returned 5.00% during the second quarter of 2025. Read more here.",
      "url": "https://finnhub.io/api/news?id=f892debf18bb28d5f4de92b2de0ead36e77ceb9bc730d5f77257082a710ef40e"
    },
    {
      "headline": "Tracking Tweedy Browne Portfolio - Q2 2025 Update",
      "source": "SeekingAlpha",
      "datetime": 1755124466,
      "summary": "Tweedy Browne\u00e2\u0080\u0099s Q2 2025 portfolio reveals disciplined value investing with key holdings in CNH, Berkshire Hathaway, and Alphabet. See more here.",
      "url": "https://finnhub.io/api/news?id=e03c713ba631d609f2c49ccff7a742056cefa93b4a09a750ba29c0e3b62a041b"
    },
    {
      "headline": "Time to Buy Eli Lilly and Other Undervalued Healthcare Stocks?",
      "source": "Yahoo",
      "datetime": 1755101820,
      "summary": "Eli Lilly, CorMedix and Johnson & Johnson represent a diversified mix of healthcare stocks with bullish catalysts",
      "url": "https://finnhub.io/api/news?id=6ae8ed4f7793c02a01e9869027bef19731999ab40c7f641e9014273649cf89e0"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "10-Q",
      "date": "2025-07-24",
      "description": "jnj-20250629.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000178/jnj-20250629.htm"
    },
    {
      "form": "13F-HR",
      "date": "2025-07-22",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000367/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-07-18",
      "description": "xslF345X05/wk-form4_1752869553.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000172/xslF345X05/wk-form4_1752869553.xml"
    },
    {
      "form": "8-K",
      "date": "2025-07-16",
      "description": "jnj-20250716.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000170/jnj-20250716.htm"
    },
    {
      "form": "4",
      "date": "2025-06-12",
      "description": "xslF345X05/wk-form4_1749760336.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000156/xslF345X05/wk-form4_1749760336.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}